MYX — Mycelx Technologies Income Statement
0.000.00%
Last trade - 00:00
- £12.41m
- £11.29m
- $10.03m
- 43
- 31
- 70
- 43
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 27 | 11.9 | 7.1 | 8.48 | 10 |
Cost of Revenue | |||||
Gross Profit | 14.1 | 6.09 | 1.59 | 3.27 | 4.44 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 22.6 | 14.3 | 12.8 | 9.58 | 13.6 |
Operating Profit | 4.36 | -2.41 | -5.65 | -1.1 | -3.57 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 4.27 | -2.5 | -5.77 | -1.13 | -3.57 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3.07 | -2.96 | -6.09 | -1.43 | -3.99 |
Net Income Before Extraordinary Items | |||||
Net Income | 3.07 | -2.96 | -6.09 | -1.43 | -3.99 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 3.07 | -2.96 | -6.09 | -1.43 | -3.99 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.154 | -0.153 | -0.327 | -0.173 | -0.18 |